Marisa Briones
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 22, 2022 | NIH | SBIR Phase II Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose. | $1.1M | BDH PHARMA LLC |
| Sep 14, 2021 | NIH | SBIR Phase II Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose. | $974K | BDH PHARMA LLC |
| Mar 4, 2020 | NIH | SBIR Phase I Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose. | $55K | BDH PHARMA LLC |
| Sep 30, 2019 | NIH | SBIR Phase I Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose. | $339K | BDH PHARMA LLC |
| Sep 16, 2019 | NIH | SBIR Phase I Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose. | $284K | BDH PHARMA LLC |
Peer ranks
Federal funding#682
Awards as PI#417
Patents#273
Companies
- BDH PHARMA LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.